Results 201 to 210 of about 100,641 (375)

Integrated PET/MRI With 11C-CFT and 18F-FDG for levodopa response difference in Parkinson’s disease

, 2023
Yi Wu, Xiaojun Xu, Xun Sun, Heng Zhai, Tao Wang, Xuebing Cao, Yan Xu   +6 more
openalex   +1 more source

Patient‐Reported Communication Decline Following Deep Brain Stimulation in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Objective decline in communication abilities following Deep Brain Stimulation (DBS) in People with Parkinson's disease (PwP) is common; however, patient perspectives remain under‐investigated. Objectives This study examined subjective change in communicative efficacy using the Communicative Participation Item Bank (CPIB) in PwP ...
Stephanie M. Simone, Federico Rodriguez‐Porcel, Travis H. Turner   +2 more
wiley   +1 more source

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.

New England Journal of Medicine, 2000
O. Rascol, D. Brooks, A. Korczyn, D. Pp, C. Clarke, A. Lang   +5 more
semanticscholar   +1 more source

Voice and Speech in Atypical Parkinsonian Disorders

Movement Disorders Clinical Practice, EarlyView.
Background Motor speech disorders are early, common, and functionally limiting features of atypical parkinsonian disorders (APDs) such as progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and multiple system atrophy (MSA). These impairments are underrecognized and undertreated in neurology clinics.
Federico Rodriguez‐Porcel, Farwa Ali, Michiko Bruno, Heather Davis Cuevas, Rohit Dhall, Kylie Dunne‐Platero, Lawrence I. Golbe, Ihtsham Haq, Nicole Herndon, Lawrence S. Honig, Kyurim Kang, Sarah Kremen, Guillaume Lamotte, Nikolaus R. McFarland, Michela Mir, Leila Montaser‐Kouhsari, Alexander Pantelyat, Joel Page, Hylan Pickett, Laura Purcell Verdun, Kelly Richardson, Jessica Shurer, Michelle Troche, Rene L. Utianski, Katya Villarreal‐Cavazos, Tuhin Virmani, Anne‐Marie Wills, as the Diagnosis and Treatment Working Group, CurePSP Center of Care (CoC) Network, Farwa Ali, Michiko Bruno, Timothy Chang, Rohit Dhall, Kimiko Domoto‐Reilly, Lawrence I. Golbe, Ihtsham Haq, Lawrence S. Honig, Sarah Kremen, Guillaume Lamotte, Zoltan Mari, Nikolaus R. McFarland, Leila Montaser‐Kouhsari, Alexander Pantelyat, Federico Rodriguez‐Porcel, Junaid Siddiqui, Jessica Shurer, Christopher Spears, Tuhin Virmani, Anne‐Marie Wills   +48 more
wiley   +1 more source

Subcutaneous Levodopa in Parkinson's Disease: A Systematic Review and Meta-Analysis. [PDF]

Eur J Neurol
Burton M, Marsden D, Harish D, Morris P, Heneghan C, Butler A, Nunan D.   +6 more
europepmc   +1 more source

Convergence Deficits in Myoclonus‐Dystonia Point to Cerebellar Impairment

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Myoclonus‐dystonia (M‐D) is a monogenic movement disorder, with proposed cerebellar dysfunction. Vergence eye movement deficits, characteristics of degenerative cerebellar disease, have not been studied in M‐D. Cerebellar transcranial alternating current stimulation (tACS) is considered a potential therapeutic approach.
Skadi Gerkensmeier, Christina Bolte, Jan‐Ole Radecke, Feline Hamami, Andreas Sprenger, Christoph Helmchen, Robert Chen, Marcus Callister, Talyta Cortez Grippe, Christine Klein, Norbert Brüggemann, Tobias Bäumer, Alexander Münchau, Anne Weissbach   +13 more
wiley   +1 more source

Prevalence of wearing-off and dyskinesia among the patients with Parkinson’s disease on levodopa therapy: a multi-center registry survey in mainland China [PDF]

, 2014
Wei Chen, Qin Xiao, Ming Shao, Tao Feng, Weiguo Liu, Xiaoguang Luo, Xiaochun Chen, Anmu Xie, Chun‐Feng Liu, Zhenguo Liu, Yiming Liu, Jian Wang, Shengdi Chen   +12 more
openalex   +1 more source

Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial

JAMA Neurology, 2017
A. Schapira, S. Fox, R. Hauser, J. Jankovic, W. Jost, C. Kenney, J. Kulisevsky, R. Pahwa, W. Poewe, R. Anand   +9 more
semanticscholar   +1 more source

Machine learning models for the prediction of levodopa response to tremor in Parkinson's disease. [PDF]

Front Aging Neurosci
Li F, Lin S, Yan R, Cui Y, Ren K, Chen Z, Ma L, Feng T.   +7 more
europepmc   +1 more source

Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease

, 2004
Katherine Deane, Sybille Spieker, Carl E Clarke   +2 more
openalex   +2 more sources